Exact Mass: 1322.7374362

Exact Mass Matches: 1322.7374362

Found 9 metabolites which its exact mass value is equals to given mass value 1322.7374362, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PIM3 34:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C61H111O28P (1322.6999136)


   

Lanthanum strontium copper oxide

Lanthanum strontium copper oxide

La1.85Sr0.15CuO (1322.774065)


   
   
   

PKI 14-22 amide,myristoylated (TFA)

PKI 14-22 amide,myristoylated (TFA)

C55H101F3N20O14 (1322.7757842)


PKI 14-22 amide,myristoylated TFA is a potent cAMP-dependent PKA inhibitor. PKI 14-22 amide,myristoylated TFA reduces the IgG-mediated phagocytic response and also inhibits neutrophil adhesion[1].

   

2-butyl-n4,n6-bis({11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl})-9,11-dimethyl-5h-[1,3]oxazolo[4,5-b]phenoxazine-4,6-dicarboximidic acid

2-butyl-n4,n6-bis({11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl})-9,11-dimethyl-5h-[1,3]oxazolo[4,5-b]phenoxazine-4,6-dicarboximidic acid

C67H94N12O16 (1322.6910404)


   

n-{6-[(17-{[5-(acetyloxy)-4-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-3-(3-oxobut-1-en-1-yl)-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl)oxy]-4-amino-2,4-dimethyloxan-3-yl}methoxycarboximidic acid

n-{6-[(17-{[5-(acetyloxy)-4-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-3-(3-oxobut-1-en-1-yl)-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl)oxy]-4-amino-2,4-dimethyloxan-3-yl}methoxycarboximidic acid

C70H102N2O22 (1322.6923872)


   

n4,n6-bis[(6s,9r,10s,13r,18as)-11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-butyl-9,11-dimethyl-5h-[1,3]oxazolo[4,5-b]phenoxazine-4,6-dicarboximidic acid

n4,n6-bis[(6s,9r,10s,13r,18as)-11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-butyl-9,11-dimethyl-5h-[1,3]oxazolo[4,5-b]phenoxazine-4,6-dicarboximidic acid

C67H94N12O16 (1322.6910404)


   

n-[(2r,3r,4s,6r)-6-{[(1s,5s,6r,9s,11e,13s,16s,17s,18s,20s,21r,22s)-17-{[(2r,4r,5s,6s)-5-(acetyloxy)-4-{[(2s,5r,6s)-5-{[(2r,4r,5r,6s)-4-hydroxy-5-{[(2s,5r,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-3-[(1e)-3-oxobut-1-en-1-yl]-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl]oxy}-4-amino-2,4-dimethyloxan-3-yl]methoxycarboximidic acid

n-[(2r,3r,4s,6r)-6-{[(1s,5s,6r,9s,11e,13s,16s,17s,18s,20s,21r,22s)-17-{[(2r,4r,5s,6s)-5-(acetyloxy)-4-{[(2s,5r,6s)-5-{[(2r,4r,5r,6s)-4-hydroxy-5-{[(2s,5r,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5,23-dihydroxy-8,12,18,20,22-pentamethyl-25,27-dioxo-3-[(1e)-3-oxobut-1-en-1-yl]-26-oxapentacyclo[22.2.1.0¹,⁶.0¹³,²².0¹⁶,²¹]heptacosa-3,7,11,14,23-pentaen-9-yl]oxy}-4-amino-2,4-dimethyloxan-3-yl]methoxycarboximidic acid

C70H102N2O22 (1322.6923872)